Procter & Gamble to approve unaudited financial results

Procter & Gamble Hygiene and Health Care Limited will hold a board meeting on November 6, 2025, to approve the unaudited financial results for the quarter ended September 30, 2025. This meeting represents a revision to previously communicated items, with the agenda now focused solely on this key financial approval.

The original letter dated September 29, 2025, outlined a broader scope for the meeting. However, the company has informed stakeholders that the board of directors will now consider only the aforementioned financial results, in compliance with Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The announcement was made by Flavia Machado, authorized signatory for Procter & Gamble Hygiene and Health Care Limited, on October 15, 2025.